日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates

COVID-19 β 变体蛋白加强疫苗在非人类灵长类动物中引发对 SARS-CoV-2 变体的持久交叉中和作用

Vincent Pavot #, Catherine Berry #, Michael Kishko, Natalie G Anosova, Lu Li, Tim Tibbitts, Dean Huang, Alice Raillard, Sylviane Gautheron, Cindy Gutzeit, Marguerite Koutsoukos, Roman M Chicz, Valerie Lecouturier

Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters

含β蛋白的双价SARS-CoV-2疫苗在恒河猴中引起持久的广泛中和作用,并在仓鼠中引起保护作用

Catherine Berry #, Vincent Pavot #, Natalie G Anosova, Michael Kishko, Lu Li, Tim Tibbitts, Alice Raillard, Sylviane Gautheron, Sheila Cummings, Dinesh S Bangari, Swagata Kar, Caroline Atyeo, Yixiang Deng, Galit Alter, Cindy Gutzeit, Marguerite Koutsoukos, Roman M Chicz, Valerie Lecouturier

Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates

基于蛋白质的 SARS-CoV-2 刺突疫苗增强剂可增强非人类灵长类动物对 SARS-CoV-2 令人担忧的变体的交叉中和作用

Vincent Pavot #, Catherine Berry #, Michael Kishko, Natalie G Anosova, Dean Huang, Tim Tibbitts, Alice Raillard, Sylviane Gautheron, Cindy Gutzeit, Marguerite Koutsoukos, Roman M Chicz, Valerie Lecouturier

Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models

mRNA COVID-19 疫苗 MRT5500 在临床前动物模型中的免疫原性和有效性

Kirill V Kalnin, Timothy Plitnik, Michael Kishko, Jinrong Zhang, Donghui Zhang, Adrien Beauvais, Natalie G Anosova, Tim Tibbitts, Josh DiNapoli, Gregory Ulinski, Peter Piepenhagen, Sheila M Cummings, Dinesh S Bangari, Susan Ryan, Po-Wei D Huang, James Huleatt, Deanne Vincent, Katherine Fries, Shrira